
TASP0390325
CAS No. 1642187-96-9
TASP0390325 ( —— )
产品货号. M34441 CAS No. 1642187-96-9
TASP0390325 是一种高亲和力的、具有口服活性的精氨酸加压素受体 1B(V1B 受体)拮抗剂,具有抗抑郁和抗焦虑活性。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥672 | 有现货 |
![]() ![]() |
5MG | ¥993 | 有现货 |
![]() ![]() |
10MG | ¥1599 | 有现货 |
![]() ![]() |
25MG | ¥3558 | 有现货 |
![]() ![]() |
50MG | ¥6154 | 有现货 |
![]() ![]() |
100MG | ¥9792 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称TASP0390325
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述TASP0390325 是一种高亲和力的、具有口服活性的精氨酸加压素受体 1B(V1B 受体)拮抗剂,具有抗抑郁和抗焦虑活性。
-
产品描述TASP0390325 is a high affinity and orally active arginine vasopressin receptor 1B (V1B receptor) antagonist with antidepressant and anxiolytic activities.
-
体外实验TASP0390325 shows a high affinity and potent antagonist activity for V1B receptors. TASP0390325 dose-dependently inhibits [3H]-AVP binding to recombinant human V1B receptors with the IC50 value of 2.72 nM. TASP0390325 also inhibits [3H]-AVP binding to rat anterior pituitary membranes, with the IC50 value of 2.22 nM. TASP0390325 potently attenuates the 2.5 nM AVP-induced increase in [Ca2+]i, with IC50 values of and 20.2 nM.Pretreatment with TASP0390325 inhibits the retention of 11C-TASP699 in a dose-dependent manner. Binding of 11C-TASP699 to monkey pituitary slices is specifically localized to the anterior lobe. The radioligand binding is inhibited by TASP0390325 in a concentration-dependent manner. The IC50 value of TASP0390325 is 2.16 nM.
-
体内实验TASP0390325 blocks the anterior pituitary V1B receptor in vivo. Oral administration of TASP0390325 antagonized the increase in plasma ACTH levels induced by CRF/dDAVP in rats, indicating that TASP0390325 blocks the anterior pituitary V1B receptor in vivo. TASP0390325 (1 mg/kg) significantly antagonizes CRF/dDAVP-induced plasma ACTH in rats.Oral administration of TASP0390325 also exerts antidepressant effects in two models of depression (a forced swimming test and an olfactory bulbectomy model).Animal Model:Male Sprague-Dawley (SD) rats (211-246 g) Dosage:0.3 and 1 mg/kg (TASP0390325 is suspended in 0.5% methylcellulose 400) Administration:Oral administration Result:Antagonized the increase in plasma ACTH levels induced by CRF/dDAVP in rats at a dose of 1 mg/kg. In contrast, 0.3 and 1.0 mg/kg itself did not significantly affect basal ACTH levels.
-
同义词——
-
通路GPCR/G Protein
-
靶点Vasopressin Receptor
-
受体Vasopressin Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number1642187-96-9
-
分子量554.44
-
分子式C25H30Cl2FN5O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 100 mg/mL (180.36 mM; 超声助溶 )
-
SMILESCl.O=C1C2=CC(OCCCN3CCOCC3)=CN=C2N=C(C=4C=CC(F)=C(Cl)C4)N1CC(=O)NC(C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. M Iijima, et al. Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325. Br J Pharmacol. 2014 Jul;171(14):3511-25.?
产品手册




关联产品
-
Lixivaptan
Lixivaptan 是一种口服活性、选择性加压素受体 V2 拮抗剂 (Ki = 2.3 nM)。
-
Fedovapagon
Fedovapagon (VA106483) 是一种选择性的加压素 V2 受体 (V2R) 激动剂,EC50 值为24 nM。Fedovapagon 可用于夜尿症的研究。
-
OPC-51803
OPC-51803 is an orally available nonapeptidylpressor (AVP) V(2) receptor selective agonist for the treatment of urinary incontinence and nocturia.